Tobramycin dry powder inhalation (PureIMS)
N/A
Report date: 2023/09/11 18:09:50
NME
Base Information
Drug NameTobramycin dry powder inhalation (PureIMS)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPureIMS BV
China Registration ClassN/A
Develop Information
Active CompaniesUmcg The University Medical Center Groningen
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A